Conservative treatments in gynaecological cancer for fertility preservation

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  Fernandez Montoli, Maria Eulalia ^a   Baldrich, Elisabeth ^b   Miralpeix, Gloria ^b   Gine Martinez, Luis ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER HORMONE THERAPY; CANCER STAGING; CERVICECTOMY; CONSERVATIVE TREATMENT; CYSTECTOMY; ENDOMETRIUM CANCER; FEMALE GENITAL TRACT CANCER; FERTILITY PRESERVATION; HUMAN; LYMPH VESSEL METASTASIS; OVARIECTOMY; OVARY TUMOR; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SALPINGOOOPHORECTOMY; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION;

EID: 85041965607     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008641.pub2     Document Type: Article

References (50)

1. Balagueró L. Borderline tumours of the ovary [Tumores borderline del ovario]. Acta Gynecology 2001;58:184-189.
2. Balagueró Lladó L, Condom Mundó E. Terminologic classification of ovarian tumours. Hystogenesis and pathology. [Clasificación terminológica de los tumores del ovario. Histogénesis y anatomía patológica]. In: Cabero L editor(s). Tratado de Ginecología, Obstetricia y Medicina de la Reproducción. 1. Madrid: Editorial Médica Panamericana, 2003:1603-1621.
3. Bosch FX, De Sanjosé S. Human papillomavirus and cervical cancer-burden and assessment of causality. Journal of the National Cancer Institute. Monographs 2003;31:3-13.
4. Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT. Outcome and reproductive function after chemo therapy for ovarian dysgerminoma. Journal of Clinical Oncology 1999;17:2670-75.
5. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The Results of Direct and Indirect Treatment Comparisons in Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
6. Burnett AF, Roman LD, O'Meara AT, Morrow CP. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecologic Oncology 2003;88(3):419-23.
7. Camatte S, Morice P, Pautier P, Atallah D, Duvillard P, Castaigne D. Fertility results after conservative treatment of advanced stage serous borderline tumor of the ovary. British Journal of Obstetrics and Gynaecology 2002;19:376-80.
8. Carmona F (Coordinator). National Inquiry: Invasive cervical Cancer [Encuesta Nacional: Carcinoma invasor del cuello uterino.]. Sección de Ginecología Oncológica y Patología Mamaria de la Sociedad Española de Ginecología y Obstetricia SEGO 2001.
9. Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstetrics and Gynecology 2003;102(4):765-73.
10. Colombo N, Parma G, Lapresa MT, Maggi F, Piantanida P, Maggioni A. Role of conservative surgery in ovarian cancer: The European experience. International Journal of Gynecological Cancer 2005;15:206-11.
11. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecological Oncology 2001;81:129-32.
12. Covens A. Preserving fertility in early stage cervical cancer with radical trachelectomy. Contemporary Obstetrics and Gynecology 2003;48:46-66.
13. Covens A. Fertility and gynecologic cancer. In: Gershenson DM, Mc Guire WP, Gore M, Quinn MA, Thomas G editor(s). Gynecologic Cancer. Controversies in Management. 1. Philadelphia: Elservier, 2004:775-84.
14. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). (http://ctep.cancer.gov/forms/CTCAEv3.pdf) August 9th 2006.
15. Dargent D, Brun JL, Roy M. Enlarged trachelectomy. An alternative to the radical hysterectomy in the treatment of infiltrant cervical cancers located in the external face of the uterine cervix [La Trachélectomie élargie (T.E.). Une alternative à ĺ hysterectomie radicale dans le traitement des cancers infiltrants développés sur la face externe du col utérin.]. Journal of Obstetrics and Gynaecology 1994;2:292-95.
16. Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000;88(8):1877-82.
17. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London:: BMJ Publication Group, 2001.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
19. Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, et al.Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999;85:2623-29.
20. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, MøllerH, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D, and the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Annals of Oncology 2003;14((Supplement 5)):v61-v118.
21. Gershenson DM. Contemporary treatment of borderline ovarian tumors. Cancer Invest 1999; 17: 206-210 1999;17:206-10.
22. Gotlieb WH, Beiner ME, Shalmon B, Korach Y, Segal Y, Zmira N, et al.Outcome of fertility sparing treatment with progestins in young patient with endometrial cancer. Obstetrics and Gynecology 2003;102:215-18.
23. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
24. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus. Usefulness and limitations. European Journal of Gynaecological Oncology 2001;22:217-20.
25. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al.Cancer Statistics. CA: A Cancer Journal for Clinicians 2008;58:71-96.
26. Jolley JA, Battista L, Wing DA. Management of pregnancy after radical trachelectomy: case reports and systematic review of the literature. American Journal of Perinatology 2007;24:531.
27. Low JJ, Perrin LC, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors: A review of 74 cases. Cancer 2000;89:397-98.
28. McHale MT, DiSaia PJ. Fertility-sparing treatment of patients with ovarian cancer. Comprehensive Therapy 1999;25:144-50.
29. Mitsushita J, Toki T, Kato K, Fugii S, Konishi I. Endometrial carcinoma remaining after pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecologic Oncology 2000;79:129-32.
30. Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertility and Sterility 2001;75:92-96.
31. Morrow C. The limits of conservative surgery for the management of ovarian cancer. Oficial Speech about Conservative Surgery in Gynecologic Oncology. Proceedings XXV Congress Sociedad Española de Ginecología y Obstetricia (SEGO). Zaragoza (Spain) 1999.
32. Niwa K, Morishita S, Hashimoto M, Yokoyama Y, Tamaya T. Conservative therapy for endometrial carcinoma in young women treated with repeated curettage and progestogen. International Journal of Clinical Oncology 1997;2:165-69.
33. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer 1993;54:594-606.
34. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
35. Plante M. Fertility preservation in the management of cervical cancer. CME Journal of Gynecological Oncology 2003;8:97-107.
36. Plante M, Renaud MC, Francois H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery: an update series of 72 cases and review of the literature. Gynecologic Oncology 2004;95:133-38.
37. Plante M. Fertility sparing surgery for invasive cervical cancer. Uptodate.com 2009:1-20.
38. Ramírez PT, Frumovitz M, Bodurka DC, Sun ChC, Levenback Ch. Hormonal therapy for management of grade I endometrial adenocarcinoma: a literature review. Gynecologic Oncology 2004;95:133-38.
39. Ramirez PT. Fertility- sparing options for treatment of women with gynecologic cancer. In: Buzdar AU, Freedman RS editor(s). Gynecologic Cancer. M.D.Anderson Cancer Care Series. 1. New York: Springer Science-Business Media. 2006 pp 244-60., 2006:244-60.
40. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstetrics and Gynecology 1997;90:434-40.
41. Rob L, Charvat M, Robova H, Pluta M, Strnad P, Hreorkak M. Less radical fertility sparing surgery than radical trachelectomy in early cervical cancer. International Journal of Gynecological Cancer 2007;17(1):304-10.
42. Roman L. The Management of Malignant Ovarian Neoplasms in the Young Patient. In: Attcheck A, Deligdisch L, Kase NG editor(s). Diagnosis and Management of Ovarian Disorders. 1. Amsterdam: Academic Press, 2003:431-39.
43. Schindler JM, Thompson AM, DePriest PD, et al.Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecologic Oncology 2002;87:1-7.
44. Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates. British Journal of Obstetrics and Gynaecology 2001;108:882-85.
45. Thigpen JT, Brady MF, Alvarez RD. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by Gynecologic Oncology Group. Journal of Clinical Oncology 1999;17:1736-44.
46. Wang CB, Wang CJ, Huang HJ, Hsueh S, Chou HH, Soong YK, et al.Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer2002;94:2192-98.
47. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.Iri.ca/programs/ceu/oxford.htm.
48. Yahata T, Fujita K, Aoki Y, Tanaka K. Long-term conservative therapy for endometrial adenocarcinoma in young women. Human Reproduction 2006;21:1070-75.
49. Zanetta G, Chiari S, Rota S, Bratina G, Maneo A, Torri V, et al.Conservative surgery for stage I ovarian carcinoma in women of childbearing age. British Journal of Obstetrics and Gynaecology 1997;104:1030-35.
50. Zanetta G, Gabriele A, Losa G, Mangioni C. Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patient. International Journal of Gynaecological Cancer 1997;7:332-34.